Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Participants Needed: International research study by OvQuest

Do you have ovarian cancer and have you received chemotherapy? Take part in an on-line international research study looking at the challenges faced by women with ovarian cancer. To help … Continue reading

July 21, 2015

Bevacizumab Plus Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer

TAKE-HOME MESSAGE  This randomized trial enrolled 361 platinum-resistant ovarian cancer patients who received single-agent chemotherapy

April 22, 2014

Chemotherapy Hypersensitivity Reactions in Ovarian Cancer

“Drug desensitization has emerged as a safe and effective way of reintroducing a chemotherapeutic agent or monoclonal antibody responsible for an HSR (hypersensitivity reaction) in a patient who is expected … Continue reading

April 1, 2014

Glutathione for Prevention of Paclitaxel/Carboplatin-Induced Peripheral Neuropathy

Despite evidence supporting the potential benefit of glutathione in the prevention of chemotherapy-induced peripheral neuropathy (CIPN), results of this trial of 185 patients showed no benefit in preventing CIPN as … Continue reading

April 1, 2014

Trends in the Treatment of Chemotherapy-Induced Peripheral Neuropathy

“…chemotherapy-induced neuropathy is a big, big problem; it is one of the more prominent toxicities we have with a number of commonly used chemotherapy agents, such as the platinum agents … Continue reading

March 17, 2014

MITO-7 Focuses on Quality of Life: Weekly Carboplatin and Paclitaxel vs the Every 3-Week Standard

“Our primary study hypothesis was that the experimental weekly schedule could produce an improvement in health-related quality of life, compared with the standard schedule.” http://www.practiceupdate.com/expertopinion/833  Following the successful completion of … Continue reading

March 17, 2014

Vitamin C ‘Gives Chemotherapy a Boost’

“The researchers injected vitamin C into human ovarian cancer cells in the lab, into mice, and into patients with advanced ovarian cancer. They found ovarian cancer cells were sensitive to … Continue reading

March 3, 2014

Patient Selection and Targeted Treatment in the Management of Platinum-Resistant Ovarian Cancer

“…there is an increasing need for the identification of response predictive biomarkers. Selecting the right patients through biomarker screening will help tailor therapy to patients and decrease superfluous treatment to … Continue reading

October 16, 2013

Nail Complications of Cancer Therapies on the Rise

“Taxanes, and specifically docetaxel, are “the worst offenders” of chemotherapies resulting in nails disorders, she said. More than 80% of patients treated with multiple cycles of docetaxel will develop some … Continue reading

September 3, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada